References
- Cook AJ, Gilbert RE, Buffolano W, Zufferey J, Petersen E, Jenum PA, et al. Sources of toxoplasma infection in pregnant women: European multicentre case-control study. European Research Network on Congenital Toxoplasmosis. Br Med J 2000; 321: 142–7.
- Dubey JP. Sources of Toxoplasma gondii infection in pregnancy. Br Med J 2000; 321: 127–8.
- Tenter AM, Heckeroth AR, Weiss LM. Toxoplasma gondii: from animals to humans. Int J Parasitol 2000; 30: 1217–58.
- Aspöck H, Pollak A. Prevention of prenatal toxoplasmosis by serological screening of pregnant women in Austria. Scand J Infect Dis Suppl 1992; 84: 32–8.
- Couvreur J. Problems of congenital toxoplasmosis. Evolution over four decades. Presse Med 1999; 28: 753–7.
- Petersen E, Eaton RB. Control of congenital infection with Toxoplasma gondii by neonatal screening based on detection of specific immunoglobulin M antibodies eluted from phenylketonuria filter-paper blood-spot samples. Acta Paediatr Suppl 1999; 88: 36–9.
- Paul M, Petersen E, Pawlowski ZS, Szczapa J. Neonatal screening for congenital toxoplasmosis in the Poznan region of Poland by analysis of Toxoplasma gondii-specific IgM antibodies eluted from filter paper blood spots. Pediatr Infect Dis J 2000; 19: 30–6.
- Logar J, Novak-Antolič Ž, Zore A. Serological screening for toxoplasmosis in pregnancy in Slovenia. Scand J Infect Dis 1995; 27: 163–4.
- Official Gazette, Art. 41. 1995; 69: 5297–300.
- Logar J, Novak-Antolič Ž, Zore A. Specific IgG avidity – a supplementary assay in serological screening for toxoplasmosis in pregnancy. J Infect 1999; 38: 61–3.
- Stray-Pedersen B. Treatment of toxoplasmosis in pregnant mother and newborn child. Scand J Infect Dis Suppl 1992; 84: 23–31.
- Foulon W. Congenital toxoplasmosis – is screening desirable. Scand J Infect Dis Suppl 1992; 84: 11–7.
- Lappalainen M, Sintonen H, Koskiniemi M, Hedman K, Hiilesman V, Ammala P, et al. Cost-benefit analysis of screening for toxoplasmosis during pregnancy. Scand J Infect Dis 1995; 27: 265–72.
- Bader TJ, Macones GA, Asch DA. Prenatal screening for toxoplasmosis. Obstet Gynecol 1997; 90: 457–64.
- Allain JP, Palmer CR, Pearson G. Epidemiological study of latent and recent infection by Toxoplasma gondii in pregnant women from a regional population in the UK. J Infect 1998; 36: 189–96.
- Jenum PA, Kapperud G, Stray-Pedersen B, Melby KK, Eskild A, Eng J. Prevalence of Toxoplasma gondii specific immunoglobulin G antibodies among pregnant women in Norway. Epidemiol Infect 1998; 120: 87–92.
- Lynfield R, Hsu HW, Guerina NG. Screening methods for congenital toxoplasma and risk of disease. Lancet 1999; 353: 1899–900.
- Foulon W, Naesens A, Ho-Yen D. Prevention of congenital toxoplasmosis. J Perinat Med 2000; 28: 337–45.
- Moor C, Sone P, Purdie G, Weinstein P. An investigation into the incidence of toxoplasmosis in pregnancy in New Zealand. N Z Med J 2000; 113: 29–32.
- Petersson KK, Stray-Pedersen B, Malm G, Forsgren M, Evengard B. Seroprevalence of Toxoplasma gondii among pregnant women in Sweden. Acta Obstet Gynecol Scand 2000; 79: 824–9.
- Couvreur J, Desmonts G, Thulliez P. Prophylaxis of congenital toxoplasmosis. Effects of spiramycin on placental infection. J Antimicrob Chemother 1988; 22 (Suppl B): 193–200.
- Desmonts G, Couvreur J. Congenital toxoplasmosis. A prospective study of the offspring of 542 women who acquired toxoplasmosis during pregnancy. In: Thalhammer O, Baumgarten K, Pollak A, eds. Perinatal medicine: Sixth European Congress. Stuttgart: Thieme, 1979 : 51–60.
- Horion M, Thoumsin H, Senterre J, Lambotte R. 20 annees de depistage de la toxoplasmose chez la femme enceinte l’experience liegeoise sur 20,000 grosseses. Rev Med Liege 1990; 45: 492–7.
- Mombro M, Petathoner C, Leone A, Nicocia M, Moiraghi Ruggerini A, Zotti C, et al. Congenital toxoplasmosis: 10 year follow-up. Eur J Pediatr 1995; 154: 635–9.
- Foulon W, Villena I, Stray-Pedersen B, Decoster A, Lappalainen M, Pinon J-M, et al. Treatment of toxoplasmosis during pregnancy: impact of foetal transmission and children’s sequelae at one year of age: a multicenter study. Am J Obstet Gynecol 1999; 180: 410–5.
- Dunn D, Wallon M, Peyron F, Petersen E, Peckham C, Gilbert R. Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling. Lancet 1999; 353: 1829–33.
- Stray-Pedersen B. Treatment of toxoplasmosis in pregnancy and the infected newborns. Abstracts of VIIIth European Multicolloquium of Parasitology in Poznan, Poland. Acta Parasitol 2000; 45: 132–S2.